Back to Search
PRAKASH SATWANI, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1033192935Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
257999(NY)
Research & Publications (20)
Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases.
PMID 17668859·Pediatr Blood Cancer·2008
6-review
Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases.
PMID 18037944·Bone Marrow Transplant·2008
6-review
Reduced-intensity conditioning allogeneic stem cell transplantation in pediatric patients.
PMID 17673890·Clin Adv Hematol Oncol·2007
8-other
Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
PMID 17241927·Biol Blood Marrow Transplant·2007
3-trial
Dysregulation of expression of immunoregulatory and cytokine genes and its association with the immaturity in neonatal phagocytic and cellular immunity.
PMID 16210844·Biol Neonate·2005
6-review
Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function.
PMID 16029458·Br J Haematol·2005
4-observational
Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges.
PMID 15931629·Biol Blood Marrow Transplant·2005
6-review
Prophylactic use of myelopoietic growth factors in children after myelosuppressive and myeloablative therapy.
PMID 14561392·Curr Hematol Rep·2003
8-other
Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning.
PMID 18785912·Pediatr Transplant·2009
8-other
Differential gene expression signatures of adult peripheral blood vs cord blood monocyte-derived immature and mature dendritic cells.
PMID 19647780·Exp Hematol·2009
4-observational
Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
PMID 19638292·Exp Hematol·2009
8-other
Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
PMID 17660841·Bone Marrow Transplant·2007
8-other
Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.
PMID 17659054·Br J Haematol·2007
8-other
A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients.
PMID 17085312·Biol Blood Marrow Transplant·2006
8-other
Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?
PMID 17008891·Leukemia·2006
5-case
Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
PMID 16737934·Biol Blood Marrow Transplant·2006
7-preclinical
Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells.
PMID 16338494·Exp Hematol·2005
4-observational
Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
PMID 16203817·Clin Cancer Res·2005
3-trial
Differential gene expression patterns by oligonucleotide microarray of basal versus lipopolysaccharide-activated monocytes from cord blood versus adult peripheral blood.
PMID 15128766·J Immunol·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3959 BROADWAY
NEW YORK, NY 10032 - Phone
- (212) 342-3929
Quick Facts
- NPI
- 1033192935
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile